We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients.
- Authors
Einbinder, Yael; Perl, Jeffrey; Nacasch, Naomi; Bnaya, Alon; Shavit, Linda; Erez, Daniel; Shashar, Moshe; Halperin, Tamar; Grupper, Ayelet; Benchetrit, Sydney; Wand, Ori; Cohen-Hagai, Keren
- Abstract
The optimal SARS-CoV-2 vaccination schedule in dialysis patients and the potential need for a fourth vaccine dose are debatable. We prospectively assessed the humoral responses to three and four doses of BNT162b2 among dialysis patients. The study included 106 dialysis patients; 60 (56.6%) and 46 (43.4%) received 3 and 4 vaccine doses, respectively. Anti-spike (anti-S) antibody titers significantly increased after the third vaccine dose, followed by a decline, yet still remained higher than all previous measurements. The fourth vaccine dose led to another profound rise in anti-S titers. The absolute increase following the fourth dose correlated with response to the third dose. Infection risk however was similar between patients vaccinated with three or four doses.
- Publication
American Journal of Nephrology, 2022, Vol 53, Issue 7, p586
- ISSN
0250-8095
- Publication type
Article
- DOI
10.1159/000525309